Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05219760
Other study ID # 2021-D0086
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 6, 2022
Est. completion date August 10, 2023

Study information

Verified date September 2023
Source University of Lausanne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial (RCT). More specifically, the investigators will test the following primary hypotheses: - Both interventions will significantly increase participants' well-being and decrease their distress, and those changes will be stable until follow-up. - LIVIA 2.0 will be more efficient than LIVIA 1 on all measure outcomes. - LIVIA 2.0 will have less dropouts than LIVIA 1.


Description:

Secondary objectives are the following: - Participants of LIVIA 2.0 will require less guidance (number of people requesting support and number of e-mails exchanged) than participants in LIVIA 1. The investigators will also explore which session triggers more requests of guidance. - Using a monitoring of participants' state throughout the completion of the programme in LIVIA 2.0, the investigators will explore the short-term efficacy of each module on participants' weekly mood, solitude feelings and grief symptoms. - The investigators will compare participants' satisfaction in both versions of LIVIA. - The investigators will also explore the role of attachment style, type of loss, relationship quality with the partner, the interpersonal closeness with the lost person, symptom severity and level of solitude at onset as moderators of the efficacy of the programmes. - The investigators will explore the semantic content of the exercises included in the programme to see if this is related with the improvement over the assessment period.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date August 10, 2023
Est. primary completion date January 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Bereavement or separation/divorce - Either of these events should have happened more than 6 months before participating in the study - Feeling the need for support to cope with the loss (a diagnosis of complicated grief is not necessary) - Age: 18 years or older - Regular Internet access - Mastery of the French language - Approved ICF Exclusion Criteria: - Moderate to acute current suicidality (SIDAS > 19) - Severe psychological or somatic disorders which need immediate treatment. - Concomitant psychotherapy - Prescription or change in dosage of psychoactive drugs in the month prior or during the self-help intervention. - Inability to follow the procedures of the study, e.g. due to comprehension problems - Enrolment of the investigator, his/her family members, employees, and other dependent persons.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LIVIA
The study aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial. Both programs are composed of 10 weekly sessions proposing educational material, questionnaires and exercises. They are based on current scientific theories of grief but present their content differently. Compared to LIVIA 1, LIVIA 2.0 is less based on academic readings and participants can choose more freely which topics and exercises they want to do. LIVIA 2.0 also offers a system of reminder messages to maximize adherence as well as more elaborate automated guidance.

Locations

Country Name City State
Switzerland University of Lausanne - Institute of Psychology Lausanne Vaud

Sponsors (1)

Lead Sponsor Collaborator
Debrot Anik

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in complicated grief symptoms assessed with a French version (Cherblanc & Zech, 2021) of The Traumatic Grief Inventory (Boelen et al., 2019), on a scale ranging from 1 = never to 5 = always. The mean score is used as a final score. Higher score represent a higher symptom load. Pretest; 12-week post-test; 3-month Follow-up
Primary Change in depression symptoms assessed with the Patient Health Questionnaire-9 (Kroenke & Spitzer, 2002; Kroenke, Spitzer & Williams, 2001), on a scale ranging from 0 = never to 4 = practically every day. The sum of the scores is used as a final score. Higher score represent a higher symptom load. Pretest; 12-week post-test; 3-month Follow-up
Primary Change in well-being measured with the French version (Villieux et al., 2016) of the Flourishing Scale (Diener et al., 2010), on a scale ranging from 1 = I completely disagree, to 7 = I completely agree. The mean score is used as a final score. Higher score represent a better psychological well-being. Pretest; 12-week post-test; 3-month Follow-up
Secondary Change in anxiety symptoms assessed with the Generalized Anxiety Scale (Micoulaud-Franchi et al., 2016; Spitzer et al., 2006), on a scale ranging from 0 = never to 4 = practically every day. The sum of the scores is used as a final score. Higher score represent a higher symptom load. Pretest; 12-week post-test; 3-month Follow-up
Secondary Change in grief coping strategies measured with the Coping with Bereavement Questionnaire (Ryckebosch-Dayez et al., 2016), on a scale ranging from 1 = almost never to 5 = always. Higher scores represent a higher use of the coping strategy. Pretest; 12-week post-test; 3-month Follow-up
Secondary Change in aspects related to identity Measured with three scales:
The Self-Concept Clarity (Brunot et al., 2015; Campbell et al., 1996) has a scale ranging from 1 = I completely disagree to 5 = I completely agree. The mean score is used as a final score. Higher score represent a lesser clarity of the self-concept.
The Centrality of Event Scale (Berntsen & Rubin, 2006; Ceschi et al., 2009) has a scale ranging from 1 = I completely disagree to 5 = I completely agree. The mean score is used as a final score. Higher score represent a higher centrality of the event of loss.
Questions about self-continuity (Lampraki et al., 2019), on a scale ranging from 1 = does not suit me to 5 = suits me perfectly. The mean score is used as a final score. Higher score represent a higher self-continuity.
Pretest; 12-week post-test; 3-month Follow-up
Secondary Satisfaction with the program (utility, clarity, impact, etc.) assessed by an adapted version of the CSQ-I The investigators will measure the satisfaction with the program, by using a translated and adapted version of the Client Satisfaction Questionnaire (CSQ-I; Boß et al., 2016) assessing different quantitative and qualitative questions. These questions will be evaluated separately. 12-week post-test
Secondary Change in the monitoring of the mood, solitude feelings and grief symptoms The investigators will weekly monitor the mood of the participants of LIVIA 2 using a single item ("How would you describe your current mood" on a scale ranging from 0 (very bad) to 6 (very good). Moreover, the investigators will weekly monitor the grief and solitude symptoms on a scale ranging from 1 (strongly disagree) to 5 (strongly agree) with the following items: "During the past 24 hours: (1) I have felt negative emotions ; (2) I have had negative images or thoughts ; (3) I felt blocked in my behaviour (what I do, my activities) ; (4) I felt lonely ; (5) I felt like I had a clear sense of who I am and what I want in life. Days 1, 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, 78, 85
Secondary Indicators of verbal immediacy (use of first-person pronouns and present tense words) and so-called "we-talk" (first-person plural pronouns) The investigators will analyse the linguistic behaviours and the semantic content in the exercises where the participants are required to describe a situation related to the loss. The objective is to test if some semantic categories (e.g. "we-talk", Bourassa et al., 2018) are associated with the efficacy of the programme. 12-week Post-test
Secondary Degree of required guidance in each group number of participants requiring guidance and number of e-mails exchanged 12-week Post-test
See also
  Status Clinical Trial Phase
Completed NCT04552717 - My Grief - an App for Parents With Prolonged Grief After Losing a Child to Cancer N/A
Recruiting NCT05026827 - Iyengar Yoga for Prolonged Grief Disorder N/A
Completed NCT05121792 - Web Based Therapist Tutorial on Prolonged Grief N/A
Completed NCT05575817 - Web Based Patient Tutorial on Prolonged Grief N/A
Withdrawn NCT01247025 - Prolonged Grief and Suicide Among Veterans N/A
Recruiting NCT04121884 - Neurophysiological Mechanisms of Accelerated Resolution Therapy (ART) N/A
Completed NCT04409821 - Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care N/A
Completed NCT04505904 - Oxytocin and Approach-avoid in Grief N/A
Withdrawn NCT03568955 - Measurement and Assessment of Prolonged Grief Disorder in Asia
Terminated NCT04547985 - Naltrexone Treatment for Prolonged Grief Disorder (PGD) Phase 4
Recruiting NCT05274841 - Systematic Support for Relatives of Palliative Care Patients N/A
Completed NCT01556048 - Pilot Study of Behavioral Activation for Prolonged Grief Phase 1
Recruiting NCT04462146 - An Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD) N/A
Completed NCT02283333 - Treatment of Prolonged Grief Disorder in Combat Veterans N/A
Enrolling by invitation NCT06017765 - Coping After Loss Through Mindfulness in Adults With Prolonged Grief Disorder N/A
Recruiting NCT05365139 - Diagnostic Tools for Identifying Prolonged Grief
Recruiting NCT00553956 - A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide Phase 1
Recruiting NCT04694807 - Cognitive Behavioural Therapy for Complicated Grief Reactions in Old Age N/A

External Links